Comparing the current results to its competitors, Journey Medical reported Revenue increase in the 1 quarter 2026 by 21.48 % year on year. The sales growth was above Journey Medical's competitors' average revenue growth of 20.79 %, achieved in the same quarter.
Journey Medical Corp, slower than the average decrease reported by the company's competitors of -27.15 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -27.15 %
Journey Medical's Comment on Competition and Industry Peers
The company faces competition primarily from manufacturers of generic versions of its products, particularly as patents or exclusivity periods expire. Competitors may develop and commercialize similar or identical products, which could limit the commercial opportunities and profitability of the company's products. Generic drug companies may also challenge the validity and enforceability of the company's patents through litigation or proceedings with the U.S. Patent and Trademark Office. The company operates in a heavily regulated industry, and future legislation or administrative actions may impact its operations. Additionally, the company relies on third parties for development, marketing, manufacturing, and sales, which may affect its ability to commercialize products effectively.
Ibio Inc is a plant-based biologics company that focuses on the development and manufacturing of therapeutic proteins. They utilize their proprietary plant-based expression system to produce biotherapeutics quickly and cost-effectively. By leveraging their platform, Ibio aims to address unmet medical needs and provide affordable and accessible treatments to patients worldwide.
Agios Pharmaceuticals Inc is a biopharmaceutical company that focuses on researching and developing innovative therapies for treating genetic diseases and cancer.
Arbutus Biopharma Corp is a biopharmaceutical company focused on discovering and developing innovative therapies for patients suffering from Hepatitis B. They aim to utilize their proprietary technologies to both advance their internal pipeline and collaborate with partners to develop a cure for Hepatitis B. Their business model revolves around leveraging their expertise and strategic partnerships to create effective treatments that address the unmet needs of Hepatitis B patients.
Abeona Therapeutics Inc is a biopharmaceutical company focused on developing gene and cell therapies for rare genetic diseases. Their business model revolves around identifying and acquiring promising technologies, conducting pre-clinical and clinical research, and eventually bringing these therapies to the market. They collaborate with academic institutions, medical centers, and patient advocacy groups to advance their pipeline and provide solutions for currently untreatable genetic disorders.
Sources:
Journey Medical Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Journey Medical Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
